Fundz

Tangen Biosciences reported raising $465,000 in an initial SEC Form D filing, from an offering of $2.5 Million

PRIVATEJun 06, 2023$464.8K of $2.5M raised

Amount Raised

$465,000

$465,000 sold, per SEC Form D (first sale May 26, 2023)

Round Type

Seed

BranfordBiotechnology

Quick answer

Tangen Biosciences raised $465,000 in a Seed round, dated May 26, 2023. Tangen Biosciences is based in Branford, Connecticut, United States.

How much did Tangen Biosciences raise?
Tangen Biosciences raised $465,000 in a Seed round on May 26, 2023.
What does Tangen Biosciences do?
Tangen Biosciences, Inc. was founded in 2013 and is located in Branford, Connecticut.
Where is Tangen Biosciences based and how big is it?
Tangen Biosciences is based in Branford, Connecticut, United States.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Tangen Biosciences that raised within 45 days of this round, from Fundz verified event records.

  • EIP Pharma, Inc. raised $810K (Seed) on July 10, 2023.
  • GENIE Therapeutics raised $50K (Pre-Seed) on July 10, 2023.
  • PainTEQ raised $35M (Grant) on July 10, 2023.
  • Microsize raised an undisclosed amount on July 10, 2023.
  • Bausch Health Companies raised $600M (Funding Round) on July 7, 2023.
  • Verismo Therapeutics raised $19M on July 7, 2023.

Who to call at Tangen Biosciences, and when

A new round usually means Tangen Biosciences is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Tangen Biosciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Tangen Biosciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Tangen Biosciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Tangen Biosciences

Location

20 COMMERCIAL STREET

Branford, Connecticut, United States

About

Tangen Biosciences, Inc. was founded in 2013 and is located in Branford, Connecticut. The company developed the TangenDx™ platform for fast and accurate detection of targeted DNAs and RNAs directly from specimens by using rotary rapid isothermal nucleic acid detection. The Tangen system consists of the TangenDx™ disc and the GeneSpark™ instrument, an automated amplification device. The TangenDx™ platform, which does not require laboratory facilities, is expected to deliver faster, simpler, more sensitive detection at a lower cost than other commercial technologies. Current tests in development include COVID-19, Candida auris, sepsis causing bacterial panel, antibiotic resistance genes, and a fungal blood panel. The system can process samples from whole blood, sputum, skin swabs, nasopharyngeal swabs, etc. The TangenDx FluA/B, RSV, and SARS-CoV-2 Panel assay planned to be released by the upcoming fall season.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Tangen Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Tangen Biosciences's next move

See what Strategic adds

Tangen Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.